Mark N Ziats1, Robin P Goin-Kochel2,3, Leandra N Berry2,3, May Ali4,5, Jun Ge4, Danielle Guffey6, Jill A Rosenfeld4, Patricia Bader7, Michael J Gambello8, Varina Wolf9, Lynette S Penney10, Ryan Miller11, Robert Roger Lebel11, Jeffrey Kane12, Kristine Bachman13, Robin Troxell14, Gary Clark9, Charles G Minard6, Pawel Stankiewicz4, Arthur Beaudet4, Christian P Schaaf4,5. 1. Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas, USA. 2. Autism Center, Texas Children's Hospital, Houston, Texas, USA. 3. Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA. 4. Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA. 5. Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, Texas, USA. 6. Dan L. Duncan Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA. 7. Northeast Indiana Genetics, Fort Wayne, Indiana, USA. 8. Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA. 9. Section of Pediatric Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA. 10. Department of Pediatrics, IWK Health Centre, Halifax, Nova Scotia, Canada. 11. Section of Medical Genetics, Department of Pediatrics, SUNY Upstate Medical University, Syracuse, New York, USA. 12. 'Specially for Children Medical Group, Austin, Texas, USA. 13. Department of Pediatrics, Geisinger Medical Center, Danville, Pennsylvania, USA. 14. University of Missouri, Columbia, Missouri, USA.
Abstract
BACKGROUND: Chromosome 15q13.3 represents a hotspot for genomic rearrangements due to repetitive sequences mediating nonallelic homologous recombination. Deletions of 15q13.3 have been identified in the context of multiple neurological and psychiatric disorders, but a prospective clinical and behavioral assessment of affected individuals has not yet been reported. METHODS: Eighteen subjects with 15q13.3 microdeletion underwent a series of behavioral assessments, along with clinical history and physical examination, to comprehensively define their behavioral phenotypes. RESULTS: Cognitive deficits are the most prevalent feature in 15q13.3 deletion syndrome, with an average nonverbal IQ of 60 among the patients studied. Autism spectrum disorder was highly penetrant, with 31% of patients meeting clinical criteria and exceeding cutoff scores on both ADOS-2 and ADI-R. Affected individuals exhibited a complex pattern of behavioral abnormalities, most notably hyperactivity, attention problems, withdrawal, and externalizing symptoms, as well as impairments in functional communication, leadership, adaptive skills, and activities of daily living. CONCLUSIONS: The 15q13.3 deletion syndrome encompasses a heterogeneous behavioral phenotype that poses a major challenge to parents, caregivers, and treating providers. Further work to more clearly delineate genotype-phenotype relationships in 15q13.3 deletions will be important for anticipatory guidance and development of targeted therapies.Genet Med 18 11, 1111-1118.
BACKGROUND: Chromosome 15q13.3 represents a hotspot for genomic rearrangements due to repetitive sequences mediating nonallelic homologous recombination. Deletions of 15q13.3 have been identified in the context of multiple neurological and psychiatric disorders, but a prospective clinical and behavioral assessment of affected individuals has not yet been reported. METHODS: Eighteen subjects with 15q13.3 microdeletion underwent a series of behavioral assessments, along with clinical history and physical examination, to comprehensively define their behavioral phenotypes. RESULTS: Cognitive deficits are the most prevalent feature in 15q13.3 deletion syndrome, with an average nonverbal IQ of 60 among the patients studied. Autism spectrum disorder was highly penetrant, with 31% of patients meeting clinical criteria and exceeding cutoff scores on both ADOS-2 and ADI-R. Affected individuals exhibited a complex pattern of behavioral abnormalities, most notably hyperactivity, attention problems, withdrawal, and externalizing symptoms, as well as impairments in functional communication, leadership, adaptive skills, and activities of daily living. CONCLUSIONS: The 15q13.3 deletion syndrome encompasses a heterogeneous behavioral phenotype that poses a major challenge to parents, caregivers, and treating providers. Further work to more clearly delineate genotype-phenotype relationships in 15q13.3 deletions will be important for anticipatory guidance and development of targeted therapies.Genet Med 18 11, 1111-1118.
Authors: Przemyslaw Szafranski; Christian P Schaaf; Richard E Person; Ian B Gibson; Zhilian Xia; Sangeetha Mahadevan; Joanna Wiszniewska; Carlos A Bacino; Seema Lalani; Lorraine Potocki; Sung-Hae Kang; Ankita Patel; Sau Wai Cheung; Frank J Probst; Brett H Graham; Marwan Shinawi; Arthur L Beaudet; Pawel Stankiewicz Journal: Hum Mutat Date: 2010-07 Impact factor: 4.878
Authors: Jill A Rosenfeld; Lindsey E Stephens; Justine Coppinger; Blake C Ballif; Joe J Hoo; Beatrice N French; Valerie C Banks; Wendy E Smith; David Manchester; Anne Chun-Hui Tsai; Katrina Merrion; Roberto Mendoza-Londono; Lucie Dupuis; Roger Schultz; Beth Torchia; Trilochan Sahoo; Bassem Bejjani; David D Weaver; Lisa G Shaffer Journal: Eur J Hum Genet Date: 2011-01-19 Impact factor: 4.246
Authors: Malte Spielmann; Gabriele Reichelt; Christoph Hertzberg; Marc Trimborn; Stefan Mundlos; Denise Horn; Eva Klopocki Journal: Eur J Med Genet Date: 2011-04-29 Impact factor: 2.708
Authors: A Masurel-Paulet; J Andrieux; P Callier; J M Cuisset; C Le Caignec; M Holder; C Thauvin-Robinet; B Doray; E Flori; M P Alex-Cordier; M Beri; O Boute; B Delobel; A Dieux; L Vallee; S Jaillard; S Odent; B Isidor; C Beneteau; J Vigneron; F Bilan; B Gilbert-Dussardier; C Dubourg; A Labalme; C Bidon; A Gautier; P Pernes; J M Pinoit; F Huet; F Mugneret; B Aral; P Jonveaux; D Sanlaville; L Faivre Journal: Clin Genet Date: 2010-02-09 Impact factor: 4.438
Authors: Nigel M Williams; Barbara Franke; Eric Mick; Richard J L Anney; Christine M Freitag; Michael Gill; Anita Thapar; Michael C O'Donovan; Michael J Owen; Peter Holmans; Lindsey Kent; Frank Middleton; Yanli Zhang-James; Lu Liu; Jobst Meyer; Thuy Trang Nguyen; Jasmin Romanos; Marcel Romanos; Christiane Seitz; Tobias J Renner; Susanne Walitza; Andreas Warnke; Haukur Palmason; Jan Buitelaar; Nanda Rommelse; Alejandro Arias Vasquez; Ziarih Hawi; Kate Langley; Joseph Sergeant; Hans-Christoph Steinhausen; Herbert Roeyers; Joseph Biederman; Irina Zaharieva; Hakon Hakonarson; Josephine Elia; Anath C Lionel; Jennifer Crosbie; Christian R Marshall; Russell Schachar; Stephen W Scherer; Alexandre Todorov; Susan L Smalley; Sandra Loo; Stanley Nelson; Corina Shtir; Philip Asherson; Andreas Reif; Klaus-Peter Lesch; Stephen V Faraone Journal: Am J Psychiatry Date: 2012-02 Impact factor: 18.112
Authors: Bradley P Coe; Kali Witherspoon; Jill A Rosenfeld; Bregje W M van Bon; Anneke T Vulto-van Silfhout; Paolo Bosco; Kathryn L Friend; Carl Baker; Serafino Buono; Lisenka E L M Vissers; Janneke H Schuurs-Hoeijmakers; Alex Hoischen; Rolph Pfundt; Nik Krumm; Gemma L Carvill; Deana Li; David Amaral; Natasha Brown; Paul J Lockhart; Ingrid E Scheffer; Antonino Alberti; Marie Shaw; Rosa Pettinato; Raymond Tervo; Nicole de Leeuw; Margot R F Reijnders; Beth S Torchia; Hilde Peeters; Brian J O'Roak; Marco Fichera; Jayne Y Hehir-Kwa; Jay Shendure; Heather C Mefford; Eric Haan; Jozef Gécz; Bert B A de Vries; Corrado Romano; Evan E Eichler Journal: Nat Genet Date: 2014-09-14 Impact factor: 38.330
Authors: Timothy P Rutkowski; Jason P Schroeder; Georgette M Gafford; Stephen T Warren; David Weinshenker; Tamara Caspary; Jennifer G Mulle Journal: J Neurosci Res Date: 2016-11-08 Impact factor: 4.164
Authors: Madelyn A Gillentine; Ricardo Lozoya; Jiani Yin; Christopher M Grochowski; Janson J White; Christian P Schaaf; Chadi A Calarge Journal: J Affect Disord Date: 2018-07-11 Impact factor: 4.839
Authors: Madelyn A Gillentine; Jiani Yin; Aleksandar Bajic; Ping Zhang; Steven Cummock; Jean J Kim; Christian P Schaaf Journal: Am J Hum Genet Date: 2017-11-09 Impact factor: 11.025
Authors: M A Gillentine; L N Berry; R P Goin-Kochel; M A Ali; J Ge; D Guffey; J A Rosenfeld; V Hannig; P Bader; M Proud; M Shinawi; B H Graham; A Lin; S R Lalani; J Reynolds; M Chen; T Grebe; C G Minard; P Stankiewicz; A L Beaudet; C P Schaaf Journal: J Autism Dev Disord Date: 2017-03
Authors: Madelyn A Gillentine; Janson J White; Christopher M Grochowski; James R Lupski; Christian P Schaaf; Chadi A Calarge Journal: J Child Adolesc Psychopharmacol Date: 2017-08-17 Impact factor: 2.576
Authors: Thomas Werge; Daniel H Geschwind; Aaron Gordon; Annika Forsingdal; Ib Vestergaard Klewe; Jacob Nielsen; Michael Didriksen Journal: Mol Psychiatry Date: 2019-11-08 Impact factor: 15.992
Authors: Kesavan Meganathan; Ramachandran Prakasam; Dustin Baldridge; Paul Gontarz; Bo Zhang; Fumihiko Urano; Azad Bonni; Susan E Maloney; Tychele N Turner; James E Huettner; John N Constantino; Kristen L Kroll Journal: BMC Biol Date: 2021-07-28 Impact factor: 7.431